{"altmetric_id":3281615,"counts":{"readers":{"mendeley":7,"citeulike":0,"connotea":0},"total":{"posts_count":1},"wikipedia":{"unique_users_count":1,"unique_users":["en:1194091"],"posts_count":1}},"citation":{"altmetric_jid":"4f6fa5133cf058f6100033ea","authors":["L. J. Herberg","I. C. Rose"],"doi":"10.1007\/bf00634458","first_seen_on":"2015-02-03T22:16:20+00:00","issns":["1432-2072"],"journal":"Psychopharmacology","last_mentioned_on":1260617198,"links":["http:\/\/dx.doi.org\/10.1007\/BF00634458"],"pdf_url":"http:\/\/link.springer.com\/content\/pdf\/10.1007%2FBF00634458.pdf","publisher":"Springer-Verlag","publisher_subjects":[{"name":"Medical And Health Sciences","scheme":"era"},{"name":"Psychology And Cognitive Sciences","scheme":"era"},{"name":"Biomedicine","scheme":"springer"},{"name":"Pharmacology\/Toxicology","scheme":"springer"},{"name":"Psychiatry","scheme":"springer"}],"scopus_subjects":["Life Sciences","Pharmacology, Toxicology and Pharmaceutics"],"subjects":["psychopharmacology"],"title":"The effect of MK-801 and other antagonists of NMDA-type glutamate receptors on brain-stimulation reward","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/effect-mk801-other-antagonists-nmdatype-glutamate-receptors-brainstimulation-reward"},"altmetric_score":{"score":3,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":3},"context_for_score":{"all":{"total_number_of_other_articles":3619418,"mean":4.9283821178971,"rank":815649,"this_scored_higher_than_pct":62,"this_scored_higher_than":2280092,"rank_type":"exact","sample_size":3619418,"percentile":62},"similar_age_3m":{"total_number_of_other_articles":92569,"mean":7.1366971955752,"rank":23472,"this_scored_higher_than_pct":73,"this_scored_higher_than":68014,"rank_type":"exact","sample_size":92569,"percentile":73},"this_journal":{"total_number_of_other_articles":1780,"mean":3.7508544125913,"rank":309,"this_scored_higher_than_pct":46,"this_scored_higher_than":830,"rank_type":"exact","sample_size":1780,"percentile":46},"similar_age_this_journal_3m":{"total_number_of_other_articles":32,"mean":3.0451612903226,"rank":7,"this_scored_higher_than_pct":78,"this_scored_higher_than":25,"rank_type":"exact","sample_size":32,"percentile":78}}},"demographics":{"users":{"mendeley":{"by_status":{"Unspecified":1,"Professor > Associate Professor":2,"Student  > Ph. D. Student":2,"Other":1,"Student  > Bachelor":1},"by_discipline":{"Medicine and Dentistry":1,"Psychology":1,"Agricultural and Biological Sciences":4,"Unspecified":1}}},"geo":{"mendeley":{"US":1,"GB":1}}},"posts":{"wikipedia":[{"title":"Dizocilpine","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=331247985#altmetric_citation_27","license":"public","citation_ids":[3281615,3281616],"posted_on":"2009-12-12T11:26:38+00:00","summary":"Dizocilpine (INN), also known as MK-801, is an uncompetitive antagonist of the N-Methyl-D-aspartate (NMDA) receptor, a glutamate receptor discovered by a team at Merck in 1982.","page_url":"http:\/\/en.wikipedia.org\/?curid=1194091","wiki_lang":"en","author":{"name":"RDBrown","url":"http:\/\/en.wikipedia.org\/wiki\/User:RDBrown"}}]}}